Skip to main content

Home/ Diseases/ Group items tagged type_2

Rss Feed Group items tagged

Matti Narkia

Prevention of insulin resistance by n-3 polyunsaturated fatty acids. - [Curr Opin Clin ... - 0 views

  •  
    Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Fedor D, Kelley DS. Curr Opin Clin Nutr Metab Care. 2009 Mar;12(2):138-46. PMID: 19202385
Matti Narkia

Sleep 'influences diabetes risk' - BBC NEWS | Health - 0 views

  •  
    Burning the candle at both ends during the working week could raise a person's risk of developing type 2 diabetes, New York researchers say. People who slept fewer than six hours a night were more likely to develop a condition that precedes diabetes than those sleeping for longer, they found. They said the study supported mounting evidence that cutting back on sleep can have a profound impact on health.
Matti Narkia

Low Vitamin D Hurts Teenagers' Hearts - 0 views

  •  
    March 11, 2009 -- Low vitamin D levels greatly increase a teenager's risk of diabetes and heart disease, Johns Hopkins researchers find. It is becoming clear that adults who get too little vitamin D are at higher risk for diabetes and heart disease. Now, it appears vitamin D levels also affect these risks earlier in life, say Johns Hopkins researchers Jared P. Reis, PhD, and colleagues.
Matti Narkia

Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes -- Ros... - 0 views

  •  
    Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Ros E. Am J Clin Nutr. 2003 Sep;78(3 Suppl):617S-625S. Review. PMID: 12936956
Matti Narkia

Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficie... - 0 views

  •  
    Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.\nBuzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB. Cancer Res. 2007 Jul 15;67(14):6745-52. PMID: 17638885 doi: 10.1158/0008-5472.CAN-06-4447
Matti Narkia

Not enough vitamin D: Health consequences for Canadians -- Schwalfenberg 53 (5): 841 --... - 0 views

  •  
    Not enough vitamin D: health consequences for Canadians. Schwalfenberg G. Can Fam Physician. 2007 May;53(5):841-54. Review PMID: 17872747 Conclusion Low levels of VTD are considered a major public health problem in Canada, especially during the winter. Those with risk factors should be screened for low 25(OH)D levels and repletion therapy instituted if needed. Researchers have estimated that the oral dose of vitamin D3 to attain and maintain 25(OH)D levels >80 nmol/L is 2200 IU/d if baseline levels are 20 to 40 nmol/L, 1800 IU/d if levels are 40 to 60 nmol/L, and 1160 IU/d if levels are between 60 and 80 nmol/L.64 We need to ensure that patients have healthy blood levels of 25(OH)D to prevent levels of parathyroid hormone from rising and to maximize absorption of calcium, magnesium, and phosphate. Positive effects on bone are marginal at best unless patients consume at least 800 IU/d of VTD. The emerging and exciting role of the VTD receptor and the actions of VTD in maintaining health in other cell types have become more apparent during the last decade.
Matti Narkia

Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vascul... - 0 views

  •  
    Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. Nascimento NR, Lessa LM, Kerntopf MR, Sousa CM, Alves RS, Queiroz MG, Price J, Heimark DB, Larner J, Du X, Brownlee M, Gow A, Davis C, Fonteles MC. Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):218-23. Epub 2005 Dec 22. PMID: 16373499 doi: 10.1073/pnas.0509779103
Matti Narkia

The Pathobiology of Diabetic Complications - Diabetes - 0 views

  •  
    The pathobiology of diabetic complications: a unifying mechanism. Brownlee M. Diabetes. 2005 Jun;54(6):1615-25. PMID: 15919781 doi: 10.2337/diabetes.54.6.1615
1 - 8 of 8
Showing 20 items per page